Evidence map›Paper›PMID 33574223›Full record

SynthesisTranslational psychiatry2021

Effects of tryptophan depletion on anxiety, a systematic review.

Simone M E Schopman, Renske C Bosman, Anna D T Muntingh, Anton J L M van Balkom, Neeltje M Batelaan

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Metabolomic changes in children with autism.World journal of clinical pediatrics · 2024
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Simone M E Schopman *Amsterdam UMC, Vrije Universiteit, Department of Psychiatry, Amsterdam Public Health institute, Amsterdam, The Netherlands. s.schopman@ggzingeest.nl.ORCID 0000-0002-1492-6950
Renske C Bosman *Amsterdam UMC, Vrije Universiteit, Department of Psychiatry, Amsterdam Public Health institute, Amsterdam, The Netherlands.ORCID 0000-0002-3143-9345
Anna D T MuntinghAmsterdam UMC, Vrije Universiteit, Department of Psychiatry, Amsterdam Public Health institute, Amsterdam, The Netherlands.
Anton J L M van BalkomAmsterdam UMC, Vrije Universiteit, Department of Psychiatry, Amsterdam Public Health institute, Amsterdam, The Netherlands.
Neeltje M BatelaanAmsterdam UMC, Vrije Universiteit, Department of Psychiatry, Amsterdam Public Health institute, Amsterdam, The Netherlands.
GGZ inGeest · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vulnerability markers for onset of anxiety disorders are scarce. In depression, patients at risk tend to respond with a negative mood to 'acute tryptophan depletion' (ATD), while healthy volunteers and current patients do not. The serotonergic system thus provides indications for vulnerability for depression. It is unknown whether ATD reveals vulnerability in anxiety too. This study systematically reviews the effects of ATD on anxiety and assesses whether challenging anxiety modifies the response. PubMed, Embase and PsychInfo were systematically searched up to April 2019 for studies in which (1) healthy volunteers or patients with a (remitted) anxiety disorder underwent ATD and (2) levels of anxiety were reported. In total, 21 studies were included. Studies conducted in healthy volunteers (n = 13), and patients with a remitted (n = 6) or current (panic, social or generalised) anxiety disorder (n = 4). Studies were mostly of poor quality and heterogeneous regarding population, challenge test used and outcome measures. ATD did not consistently affect anxiety in any of the groups. Moreover, a challenge test after ATD (n = 17 studies) did not consistently provoke anxiety in healthy volunteers or remitted patients. A 35% CO

Indexed as

Anxiety DisordersTryptophanAffectAnxietyDouble-Blind MethodHumansTryptophan

Identifiers

PMID33574223
PMCPMC7878770
OpenAlexW3127978514

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.